A fundamental article in the field of Brachytherapy as a treatment for prostate cancer. The article proved, using the collection of long-term oncologic results, that the method was a possible alternative to radical prostatectomy. Clinical indications and technical details also outlined.

Does Brachytherapy have a role in the treatment of prostate cancer?, 1996

This is the article responsible for bringing Brachytherapy to the attention of America. A famous figure describes his battle with prostate cancer.

Taking on prostate cancer, 1996

Publication about long-term results (10 years) in patients treated with Brachytherapy for prostate cancer. The Authors belong to the Northwest Prostate Institute of Seattle, one of the most famous centers in the U.S.

Ten-year disease free survival after transperineal sonografy-guided Iodine-125 Brachytherapy with or without 45-Gray External Beam Irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma, 1998

Results after 12 years published by the Northwest Prostate Institute in Seattle

Modern prostate Brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up, 2000

John Blasko, recognized leader in modern prostatic brachytherapy describes his long-term experiences of patients implanted with Palladium 103

Palladium-103 Brachytherapy for prostate carcinoma, 2000

This article described the series and the technique of the Mount Sinai Medical Center in NY, one of the referral centers in the U.S.

Prostate Brachytherapy: treatment strategies, 1999

If the same oncologic results are obtained from different treatments then quality of life plays a central role in a patient's decision as to which treatment option to select. By means of one of the most widely used questionnaires, quality of life after BT is examined.

A preliminary analysis of health-related quality of life in the first year after permanent source interstitial Brachytherapy (PIB) for clinically localized prostate cancer, 2000

Brachytherapy preserves normal and spontaneous sexual function in most patients as it spares neurovascular bundles (nerve-sparing treatment). The efficacy of VIAGRA in patients with erectile dysfunction after the implant confirms it.

Efficacy of sildenafil citrate in prostate Brachytherapy patients with erectile dysfunction, 1999

This article is illustrated with tables which show that the state of prostate carcinoma can be accurately gauged using PSA levels, clinical study and Gleason score (histological biopsy score)

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer, 1997

This paper outlines the guidelines of the American Brachytherapy Society for transperineal permanent prostate Brachytherapy

American Brachytherapy Society (ABS) recommendations for transperineal permanent Brachytheray of prostate cancer, 1999

This paper outlines the guidelines of the American Brachytherapy Society for post-implant dosimetric coverage (for Specialist reading only).

The American Brachytherapy Society recommendations for permanent prostate Brachytherapy postimplant dosimetric analysis, 2000

AAPM (American Association of Physicists in Medicine) presents state of the art in modern permanent prostatic brachytherapy and guidelines for implant planning and dosimetry (for Specialist reading only).

Permanent prostate seed implant Brachytherapy: report of the American Association of Physicists in Medicine TG 64, 1999